Background: Childhood tuberculosis (TB) is acquired after exposure to an infectious TB case, often within the household. We prospectively screened children 6-59 months of age, exposed and unexposed to an infectious TB case within the same household, for latent tuberculosis infection (LTBI), in Dar es Salaam, Tanzania. Methods: We collected medical data and clinical specimens (to evaluate for helminths, TB and HIV coinfections) and performed physical examinations at enrollment and at 3-month and 6-month follow-up surveys. LTBI was assessed using QuantiFERON-TB Gold (QFT) at enrollment and at 3 months. Results: In total, 301 children had complete data records (186 with TB exposure and 115 without known TB exposure). The median age of children was 26 months (range: 6-58); 52% were females, and 4 were HIV positive. Eight children (3%) developed TB during the 6-month follow-up. We found equal proportions of children with LTBI among those with and without exposure: 20% (38/186) versus 20% (23/115) QFT-positive, and 2% (4/186) versus 4% (5/115) indeterminate QFT. QFT conversion rate was 7% (22 children) and reversion 8% (25 children). Of the TB-exposed children, 72% initiated isoniazid preventive therapy, but 61% of parents/caregivers of children with unknown TB exposure and positive QFT refused isoniazid preventive therapy. Conclusions: In this high burden TB setting, TB exposure from sources other than the household was equally important as household exposure.
T uberculosis (TB) continues to claim the lives of infected children younger than 5 years and has been identified among the top 10 causes of death in this age group. 1 Young children typically acquire Mycobacterium tuberculosis infection from an infectious adult with pulmonary TB within the same household. Children with latent tuberculosis infection (LTBI) are at high risk of progressing to active TB disease within 12 months after infection, 2 and the risk is highest among children whose mothers are index cases. 3, 4 Contact tracing and isoniazid preventive treatment (IPT) are recommended by the World Health Organization (WHO) to prevent active TB disease among high-risk populations, including children younger than 5 years of age. However, IPT uptake is a challenge; only 7% of children eligible for IPT received medication in 2015 worldwide. 5 Despite the WHO's emphasis on providing TB-preventive therapy, contact tracing remains a largely neglected part of TB control in high-burden countries due to lack of financial and human resources, coupled with the high costs associated with diagnostics and contact tracing itself. 6 High-income countries mostly use interferon-γ release assay (IGRA) for TB contact tracing, which has high specificity for detecting M. tuberculosis infection but limited sensitivity, particularly in children. 7 Most TB programs in lowincome countries and high TB-incidence rates use tuberculin skin test instead of IGRA, such as the ELISpot-based test (T-SPOT.TB) and the enzyme-linked immunosorbent assay-based test Quanti-FERON-TB Gold (QFT), which are restricted to research use only in these settings. [8] [9] [10] Due to the limitations of IGRAs for the diagnosis of LTBI in children in high TB incidence countries, a quantified exposure score was recently proposed to serve as a surrogate measure of M. tuberculosis infection, specifically in TB-exposed children. 8, 11 In Tanzania, the National TB and Leprosy Control Program (NTLP) reported that childhood TB cases constituted 10% of the country's TB cases in [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] . 12 To interrupt transmission of TB and combat the childhood TB epidemic in the country, since 2013, the program has been working to improve childhood TB case detection and reporting. However, the yield of infection screening, particularly among children without documented TB exposure, and the implications for screening strategies in routine settings have not yet been investigated. 13 We conducted a prospective study among children younger than 5 years of age exposed to infectious pulmonary TB cases in their households and controls from neighboring households, to assess the prevalence of LTBI among children younger than 5 years of age in a high TB burden setting in Tanzania, using immunodiagnostic tests and a quantified TB exposure score.
MATERIALS AND METHODS

Study Setting and Design
Temeke is 1 of 3 districts in Dar es Salaam, the economic capital of Tanzania, with an estimated 1.4 million residents. The under-5 mortality in Dar es Salaam is 62 per 1,000.
14 In 2014, TB prevalence in adults was 270 per 100,000 population in Temeke. 15 HIV prevalence among pregnant mothers in the district is estimated to be 6%. 16 The NTLP conducts routine contact tracing of young children by counselling smear-positive adult TB cases to bring children younger than 5 years of age from their households for symptom-based TB screening and IPT if not found to have disease.
We conducted a prospective study in Temeke District among TB-exposed children, with the overarching aim of exploring TB/ helminth coinfection, as previously described. 17 To recruit controls, we invited children from neighboring households according to standard operating procedures (Text, Supplemental Digital Content 2, http://links.lww.com/INF/D202) 18 and after asking if there was an adult on TB treatment or suspected of having TB in the household. Children were referred to the Reproductive and Child Health Clinic at Temeke Municipal Council Hospital (where children younger than 5 years of age are typically seen) for enrollment and follow-up visits at 3 and 6 months after enrollment ( 
Study Population and Sample Size Consideration
We invited 398 parents/caregivers of children 6-59 months of age, between October 2015 and September 2016. Children were included if (1) their parents/caregiver provided written informed consent, (2) they were 6-59 months of age at the time of enrollment, (3) they resided within Temeke District and would continue to do so in the next 6 months after enrollment, and (4) they lived with a smear-positive adult pulmonary TB case, as diagnosed by sputum smear microscopy and culture 19 (for case children) or came from households without documented TB case (for control children) (Text, Supplemental Digital Content 2, http://links.lww. com/INF/D202). Children with known TB exposure were recruited within a month of the index case starting TB treatment.
We aimed for a sample size of 300 children 6-59 months of age, with 150 TB-exposed and 150 TB-unexposed children. This sample size was estimated to provide a precision of 5% in estimating TB infection prevalence, with an error probability of 5%.
Study Procedures At Enrollment
The study clinician collected demographic and socioeconomic information and, using a standardized case report form, evaluated children for the following TB signs and symptoms: (1) current cough of any duration, (2) abnormal fatigue or reduced playfulness, (3) documented weight loss or failure to thrive in the past 3 months, (4) axillary temperature >37.5°C, (5) visible cervical mass (>2 × 2 cm), (6) gibbus (sharp angular spine deformity), and (7) other signs suggestive of possible extrapulmonary TB. The clinician also collected histories on feeding practices, prior illnesses (including TB), previous use of IPT and other medications and recorded vaccination history [including Calmette-Guérin bacillus (BCG) vaccination], which was verified on the Reproductive and Child Health card. All children had chest radiographs taken. Chest radiograms were interpreted by 2 independent radiologists; in case of discrepancies, a third radiologist was asked to resolve the discrepancies. Trained study nurses recorded anthropometric measurements, including height and weight, and collected venous blood for QFT, full blood counts, HIV testing and malaria screening (see also the section on "Laboratory Procedures" below). The nurses also performed sputum induction the morning after enrollment and collected induced sputum samples for Xpert MTB/RIF (Cepheid, Sunnyvale, CA). 20, 21 Parents/caregivers were given 2 prelabeled containers and were instructed to bring urine and stool samples from their children the following day for screening of helminth infection. Additionally, each participant was provided with a plastic pocket that had an adhesive tape (50 × 20 mm) and a prelabeled glass slide and asked to submit the slide with anal adhesive tape for Enterobius vermicularis examination.
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At 3-Month and 6-Month Follow-Up Visits
Children were clinically evaluated for TB and other medical conditions. We collected blood samples for QFT analysis at the 3-month visit and for full blood counts at the 6-month visit. Clinical management was determined based on case presentation.
TB Exposure Score
We used a TB exposure score chart, adopted from South Africa, to assess TB exposure. 11 The chart consists of 10 questions: 
Screening for and Diagnosing Active TB Disease
We used a comprehensive symptom-based TB tool to screen for active TB disease at each visit (Table, Supplemental Digital Content 3, http://links.lww.com/INF/D203). At baseline, in addition to symptom-based screening, we performed chest radiogram and Xpert MTB/RIF for every child within 3 days after enrollment (see also the section on "Laboratory Procedures" below). At follow-up visits, we used the symptom-based screening tool; radiogram and/or Xpert MTB/RIF were ordered only if there was an indication. Confirmation and final diagnosis were based on clinical evaluation, chest radigraphic findings and Xpert MTB/RIF, according to Cuevas et al. 23 Children known to have TB exposure but without active disease were started on IPT (20 mg/kg), in accordance with the Tanzanian NTLP treatment guideline. 12 Parents/caregivers of children with positive QFT results but without documentation of exposure to an infectious TB case were counselled and advised to start their children on IPT. Children diagnosed with TB were referred to NTLP for TB treatment. All children diagnosed with medical conditions were clinically managed in accordance with Tanzanian national guidelines.
Laboratory Procedures Microbiologic Investigations
We performed Xpert MTB/RIF (Cepheid; Sunnyvale, CA) on the induced sputum samples 20 
QuantiFERON-TB Gold (QFT)
We used venous blood to measure M. tuberculosis-specific T-cell responses, measuring levels of interferon-γ (IFN-γ) released in whole blood in response to stimulation with the M. tuberculosisspecific antigens. The blood was collected in three QFT tubes (QuantiFERON-TB Gold, Cellestis; Carnegie, Victoria, Australia): TB-Ag (coated with MTB specific antigens), Mitogen (positive control coated with phytohaemaggluttin), and Nil (negative control coated with saline). The blood was transferred to the laboratory within 1 hour and incubated at 37ºC for 16-18 hours. After incubation, the samples were centrifuged and supernatants stored at −80°C pending further processing by enzyme-linked immunosorbent assay to detect IFN-γ response associated with M. tuberculosis infection. Results were interpreted according to the manufacturer's instructions.
Other Blood Tests
HIV screening was done with Alere Determine HIV-1/2 (Alere, Holliston, MA) among children ≥18 months of age or PCR for children <18 months of age. Full blood cell counts were done using a MS4 Vet hematology analyzer (Diamond Diagnostics, Holliston, MA).
Helminth Investigations
Stool and urine samples were examined for helminth infections using the Kato-Katz, FLOTAC, Baermann, direct microscopy methods, and a point-of-care circulating cathodic antigen urine cassette test for Schistosoma mansoni diagnosis, as previously described.
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Definitions
We recorded clinical data directly onto tablet computers using the open-source software, open data kit (ODK; http://opendatakit. org/), and the data management tool, "odk_planner." 24 The TB exposure score was categorized into not likely to have TB infection (with a score of 1-6) or presumptive TB infection (score of ≥7). A composite QFT result was defined as positive QFT at either baseline or 3-month follow-up. A child was considered TB infected if the QFT result was positive. A child was considered to have active TB (probable or possible diagnosis) according to international consensus from an expert panel. 25 Chest radiograph features suggestive of TB included consolidation, cavities and hilar lymphadenopathy. Children diagnosed with active TB disease 3 months after enrollment were defined as coprevalent TB cases, while children diagnosed with TB 3 months after enrollment were defined as incident TB cases. 8 Anemia was defined as hemoglobin (Hb) <11.0 g/dL, as per WHO recommendations, further stratified into mild (Hb: 10-10.9 g/dL), moderate (Hb: 7.0-9.9 g/dL) and severe anemia (Hb: <7.0 g/dL). 26 Anthropometric Z scores were calculated using the 2006 WHO Growth Standards in Stata version 13.1 (Stata Corp, LLC; College Station, TX), using the "zscore06" command. 27 Helminth infection was defined as infection with any of the following helminth species: Ascaris lumbricoides, E. vermicularis, Hymenolepis diminuta, hookworm, Schistosoma haematobium, Schistosoma mansoni, Strongyloides stercoralis, and Trichuris trichiura.
Statistical Analysis
Frequencies and proportions were used to describe the children's demographic and clinical characteristics, both overall and stratified according to the presence or absence of documented TB exposure. QFT indeterminate results were excluded in the LTBI risk factor analysis. We performed mixed logistic regression analyses to identify risk factors for LTBI, taking into account the matching of TB-exposed and unexposed children. These analyses were conducted with and without interaction terms between the respective risk factor variables and TB-exposure status. Additionally, we ran stratified analyses separating TB-exposed and unexposed children.
We generated an exposure scale based on the TB exposure score (0, no exposure; 1-4, minimal exposure; 5-6, medium exposure, and 7-10, maximum exposure). We constructed a core multivariable mixed logistic regression model for QFT conversion and reversion between baseline and follow-up, comprising age, sex, and lymphocyte count and alternatively added TB exposure, IPT during follow-up and helminth infection as potential risk factors for QFT conversion and reversion. For children documented to have TB exposure, we also added TB exposure score and mother being index case as potential risk factors for QFT conversion and reversion. We also presented graphically the paired QFT results at enrolment and after 3 months, separately for QFT converters and reverters to illustrate the distribution of IFN-γ values during the 2 visits for children who converted to QFT positive, reverted to QFT negative and those who did not change. All analyses were performed in Stata version 13.1 (Stata Corporation, College Station, TX). 
Ethical Considerations
RESULTS
Children Baseline Characteristics
Of the 398 children 6-59 months of age invited to participate in the study, 325 parents/caregivers provided written informed consent, and hence, their children were enrolled. Clinical, demographic, and socioeconomic information were obtained from 316 children. Fifteen children did not provide blood samples for QFT analysis; thus, 301 children were included in the final analysis ( Among the 301 child participants, 186 (62%) were exposed to adults with smear-positive pulmonary TB, and 115 (38%) were not known to have been exposed to TB. Overall, the median age was 26 months (range: 6-58 months); 156 (52%) were females and 4 were HIV-positive (Table, Supplemental Digital Content 4, http:// links.lww.com/INF/D204). All children were BCG vaccinated based on vaccination documents. TB-exposed children were, on average, older than children without known TB exposure. Ninetyfive (32%) children presented with signs and symptoms suggestive of TB ( A total of 8 (2.7%) children developed active TB during follow-up (6 in the exposed and 2 in the unexposed group). All TB cases were diagnosed based on a clinical case definition, 25 which included patient's history, chest radiography, positive response to anti-TB medication, and evidence of TB infection. Five children (1.7%) were considered coprevalent TB cases (3 exposed to infectious TB cases); 4 of them were <2 years, 4 were males and 1 was HIV positive. Three children were considered incident TB cases; 1 was <2 years, and none was HIV positive. The proportion of children with active TB (prevalent and incident) in the exposed and nonexposed group was statistically not significantly different (3.2% vs. 1.7%; P = 0.44). Children exposed to HIV-seropositive mothers were not more likely to have active TB compared with HIV nonexposed children (7% vs. 2%; P = 0.15). All children with TB had mild or moderate anemia.
Prevalence of LTBI in TB-exposed and Unexposed Children
At enrollment, 15% (27/186) of TB-exposed children were QFT-positive compared with 10% (12/115) of children without documented TB exposure (P = 0.37). Indeterminate QFT results were also equally distributed between the 2 groups [9/115 (8%) vs. 9/186 (5%); P = 0.37]. At the 3-month follow-up visit (composite results), QFT was positive in 20% (61/301) children: 20% (38/186) of TBexposed versus 20% (23/115) of TB-unexposed (P = 0.9), as shown in Table 1 . The prevalence of indeterminate results was 3% (9/301).
Of those children diagnosed with active TB during followup, 10% (4/39) had a positive QFT result at enrolment. Among coprevalent TB cases, 2/5 had positive QFT results and 2/3 incident TB cases were QFT positive.
A fitted model, taking clustering into account, did not suggest any correlation between QFT-positive results (indicating LTBI) and the TB exposure score (odds ratio 1.06; 95% confidence interval: 0.81-1.40; P = 0.7). There was also no correlation between LTBI and the presence of a BCG scar; all children had a documented BCG vaccination.
Risk Factors for LTBI
We found that TB-exposed children from households with up to 5 members had a higher risk of having LTBI (defined as a positive QFT test result) compared with all other children (odds ratio 3.57; 95% confidence interval: 1.54-7.69; P = 0.003; Table 2 ). All other risk factors such as age, sex, lymphocyte count, having a mother with TB, sleeping in the same bed as the index case, and household income showed no association. Among children without documented TB exposure, none of the risk factors showed significant association with LTBI.
QFT Conversion, Reversion, and Associated Patient Factors
Forty-seven (16%) children had different QFT results when retested at the 3-month visit: 22 (8%) children converted to QFTpositive at the 3-month follow-up, 11 (50%) of which had documented TB exposure. Twenty-five children (8%) reverted to negative QFT results at the 3-month follow-up. Considering variables such as sex, age category, average BCG scar size, lymphocyte counts, an index mother, isoniazid uptake, and infection with any helminth, we found none of the factors to be predictive for either QFT conversion or reversion (Table, Supplemental Digital Content 6, http://links.lww.com/INF/D206). Neither were coprevalent TB cases and incident cases associated with QFT conversion or reversion. Figure 1 shows the paired semiquantitative QFT results at enrolment and at the 3-month follow-up visit.
IPT Uptake Among TB-exposed and Unexposed Children
By the 6-month visit (end of follow-up), 72% (133/186) children exposed to an infectious TB case had started IPT (Table 1) , and 28% (53/186) did not start IPT. Among the 53 who did not start IPT, 57% (30/53) parents/caregivers refused IPT, and 43% (21/53) were lost to follow-up. Among the 133 children who started IPT, 3% (4/133) developed active TB later on (2 coprevalent and 2 incident cases) and were started on anti-TB medications. Of the 53 exposed children who (20) 1 (20) *Applicable to TB-exposed group only based on TB exposure score based on Mandalakas et al. 11 †Diagnosed within 3 months of enrollment. ‡Diagnosed after 3 months after enrollment. LTBI was defined as positive QuantiFERON-TB Gold at either baseline or 3-month follow-up (composite QFT result). Children who developed TB during follow-up are included in this analysis. were not started on IPT, 6% (2/53) developed TB disease and started anti-TB medications (1 coprevalent and 1 incident case).
Among 115 children with undocumented TB exposure, 20% (23/115) had an LTBI diagnosis based on QFT testing. Of these 23 children, 1 child started IPT and 1 child developed TB later on (coprevalent case) and was started anti-TB medication, 61% (14/23) of parents/caregivers refused IPT and 30% (7/23) were lost to follow-up.
DISCUSSION
We present findings from a prospective study of 186 TBexposed children 6-59 months of age and 115 unexposed controls, who were followed up for 6 months in the Temeke District in Tanzania's economic capital of Dar es Salaam, characterized by high TB notification rate. QFT diagnosed equal proportions of children with LTBI in the 2 groups. IPT uptake was low among TB-exposed children, and even lower among children with undocumented TB exposure.
We showed that, overall, TB infection among exposed children, younger than 5 years of age, was low, but interestingly similar proportions of children in the 2 groups (TB-exposed and unexposed) were diagnosed with LTBI. The positive QFT results among children who did not have known exposure to TB is likely the result of community exposure to infectious TB cases. Previous studies have suggested that young children are more likely to be infected in domiciliary settings, [28] [29] [30] but due to the high prevalence of the disease in our setting, community exposure cannot be ruled out. Our findings show a higher proportion of LTBI among TB-unexposed children (20%) compared with other studies that assessed LTBI by QFT in children younger than 5 years of age (range: 2.2%-17.9%). [31] [32] [33] Previously documented reasons associated with LTBI among children include visiting other households and poor ventilation in the visited households. 30 However, our reported proportion of LTBI was considerably lower compared with other studies that report LTBI prevalence as high as 49%. 8 The lower LTBI prevalence in our study population may be due to a timely TB diagnosis in index cases, resulting in lower risk of transmission. Children from larger households were less likely to have QFT-positive results, indicating lower transmission resulting from less exposure time to an infectious TB case. 30 Our results suggest that IPT implementation in our study population remains a challenge. Indeed, about a third of the children eligible for IPT had not yet started treatment, as recommended by WHO in its roadmap for childhood TB. 34 It should be noted, however, that a study in India reported a much lower uptake (22%), while more than half of the exposed children in our study were on medication. 35 High-income settings use IGRA for TB screening, while many under-resourced settings use symptomatic screening techniques to initiate TB preventive therapy, due to high cost of IGRA tests. 8, 10 The WHO recommends IPT in all children younger than 5 years of age who are in contact with an infectious TB case or with proven TB infection after excluding active disease. 34, 36 IGRAs could be a useful tool to guide delivery of IPT in TB high burden settings, but screening strategy must consider transmission dynamics and population characteristic unique to each setting. This policy-practice gap that exists in high-burden settings needs to be addressed provided resources allow.
Contrary to other studies, our findings show a small proportion of children with indeterminate QFT results. The prevalence of indeterminate QFT results varies, especially among children. 32, [37] [38] [39] [40] For instance, Italy reported a prevalence of 0.6%, while in South Africa, a prevalence of 2.5% was found. Compared with those 2 countries, our prevalence was considerably higher. 8, 32 Malnutrition, helminth infection, and HIV infection are reportedly associated with indeterminate QFT results. 38, 40 However, in our study population, the proportion of indeterminate results was low even after repeating the test at the 3-month follow-up visit and considering composite QFT results, which we used to define the final results. Contrary to other studies, we did not find any association between indeterminate QFT results and helminths. 38 Overall, a low proportion of children had active TB disease at the end of follow-up visit. Despite the high risk of disease progression in young children after TB infection, the number of children developing active TB disease in our cohort was very low compared with those in Italy, where 5% of children developed active TB disease. 32 The majority of children diagnosed with active TB did not have radiologic findings consistent with active TB disease. This might be explained by a mild form of the disease diagnosed during presentation. However, in children, absence of radiologic findings can be explained by transient radiologic changes and the natural history of primary TB complex, which self-cures without intervention. 2 Due to the low number of incident cases, we did not find sufficient evidence for risk factors associated with active disease. Despite systematic and thorough screening of active TB disease, none of the TB cases, neither coprevalent nor incident TB cases, were microbacteriologically confirmed with Xpert MTB/RIF. Although this may be due to the paucibacillary nature of childhood TB, this finding may also reflect early diagnosis of the disease at presentation in our study.
Our study has strengths and limitations to be considered. We encountered a few challenges, mainly during enrollment, that are worth highlighting. Several parents/caregivers, especially those whose children had no history of TB exposure, were reluctant to subject their children for screening and were concerned with the sputum induction procedure despite intensive counseling. All children were systematically screened for TB, HIV, malaria, and helminth infection, as all of these diseases contribute to morbidity and mortality in this age group.
In conclusion, our findings suggest that nonhousehold transmission of TB occurs at significant rates and warrants consideration of screening among young children in high TB incidence countries. Similar to many other settings, IPT uptake among children exposed to an infectious TB case is far below the global target of 90%, as set by WHO. Contact tracing of young children remains an important strategy to prevent active TB disease. To attain this, a road map to zero TB deaths among children emphasizes, among other issues, the collective responsibility of the health system, greater awareness among healthcare providers and increased childhood TB screening. 34 Integrating routine pediatric TB screening with child health clinics will enhance awareness to the community and advocate for early screening among young children suspected to have TB. [41] [42] [43] In TB-endemic settings where TB exposure in the community is high, strategies to evaluate TB infection should not be limited to child contacts only.
